BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9660030)

  • 1. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?
    Chen H; Hardacre JM; Uzar A; Cameron JL; Choti MA
    J Am Coll Surg; 1998 Jul; 187(1):88-92; discussion 92-3. PubMed ID: 9660030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic neuroendocrine metastases: does intervention alter outcomes?
    Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
    J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
    Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
    Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
    Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
    Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
    Mazzaglia PJ; Berber E; Milas M; Siperstein AE
    Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of liver metastases in patients with neuroendocrine tumors.
    Frilling A; Rogiers X; Malagó M; Liedke OM; Kaun M; Broelsch CE
    Langenbecks Arch Surg; 1998 Mar; 383(1):62-70. PubMed ID: 9627173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
    Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
    J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
    Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
    Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
    Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
    Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
    Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
    Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
    Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
    Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for metastatic neuroendocrine tumors.
    Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
    Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoablation and liver resection for noncolorectal liver metastases.
    Goering JD; Mahvi DM; Niederhuber JE; Chicks D; Rikkers LF
    Am J Surg; 2002 Apr; 183(4):384-9. PubMed ID: 11975925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplant for Metastatic Neuroendocrine Tumors: A Single-Center Experience in Hungary.
    Korda D; Doros A; Piros L; Gerlei Z; Haboub-Sandil A; Mándli T; Fazakas J; Deák ÁP; Máthé Z
    Transplant Proc; 2019 May; 51(4):1251-1253. PubMed ID: 31101208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
    Søndenaa K; Sen J; Heinle F; Fjetland L; Gudlaugsson E; Syversen U
    World J Surg; 2004 Sep; 28(9):890-5. PubMed ID: 15593463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
    Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
    Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.